Caption Management, LLC Glaukos Corp Transaction History

Caption Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$59.53 - $85.11 $352,596 - $504,106	-5,923 Reduced 15.59%	32,068 $2.55 Million
Q3 2023 Nov 14, 2023	BUY	$69.23 - $79.09 $2.63 Million - $3 Million	37,991 New	37,991 $2.86 Million
Q1 2023 May 15, 2023	BUY	$43.88 - $52.48 $2.02 Million - $2.42 Million	46,146 Added 638.79%	53,370 $2.67 Million
Q4 2022 Feb 14, 2023	BUY	$40.82 - $57.75 $265,289 - $375,317	6,499 Added 896.41%	7,224 $315,000
Q3 2022 Nov 14, 2022	BUY	$46.84 - $58.49 $33,959 - $42,405	725 New	725 $39,000
Q1 2022 May 13, 2022	SELL	$44.33 - $57.82 $445,250 - $580,744	-10,044 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$40.27 - $56.99 $404,471 - $572,407	10,044 New	10,044 $446,000
Q4 2020 Feb 16, 2021	SELL	$48.9 - $75.26 $1.32 Million - $2.04 Million	-27,042 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$37.23 - $50.97 $1.01 Million - $1.38 Million	27,042 New	27,042 $1.34 Million

342

46.8M

132K

188K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $7.45B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.